Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer
Condition(s):Carcinoma, Transitional CellLast Updated:August 21, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Carcinoma, Transitional CellLast Updated:August 21, 2023Terminated
Condition(s):S-1 Plus OxaliplatinLast Updated:January 5, 2021Unknown status
Condition(s):Gastrointestinal CancerLast Updated:May 31, 2012Unknown status
Condition(s):Hepatocellular Carcinoma, Unresectable, AdvancedLast Updated:August 26, 2022Completed
Condition(s):Gastric CancerLast Updated:July 8, 2019Unknown status
Condition(s):Colon AdenocarcinomaLast Updated:March 30, 2021Completed
Condition(s):Overall SurvivalLast Updated:March 29, 2023Completed
Condition(s):Peritoneal CarcinomatosisLast Updated:September 29, 2022Recruiting
Condition(s):Colorectal Adenocarcinoma; OesogastricLast Updated:September 18, 2023Terminated
Condition(s):Colorectal CancerLast Updated:July 19, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.